Clinical trial
Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization.
NCT01205776 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization.
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 29, 2010
- Completion date
- June 28, 2019
- Enrollment
- 1,905 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic coronary occlusion, coronary artery disease, coronary artery stenosis, coronary disease, coronary restenosis, myocardial ischemia, stent thrombosis, unprotected left main coronary artery disease, vascular disease